Javascript must be enabled to continue!
TEAD4/YAP1/WWTR1 prevent the premature onset of pluripotency prior to the 16-cell stage
View through CrossRef
Abstract
In the mouse embryo, pluripotent cells arise inside the embryo around the 16-cell stage. During these early stages,
Sox2
is the only gene whose expression is known to be induced specifically within inside cells as they are established. To understand how pluripotent cells are created, we investigated the mechanisms regulating the initial activation of
Sox2
expression. Surprisingly,
Sox2
expression initiated normally in the absence of both
Nanog
and
Oct4
, highlighting differences between embryo and stem cell models of pluripotency. However, we observed precocious, ectopic expression of
Sox2
prior to the 16-cell stage in the absence of
Yap1, Wwtr1
, and
Tead4
. Interestingly, the repression of premature
Sox2
expression was sensitive to LATS1/2 activity, even though it normally does not limit TEAD4/YAP1/WWTR1 activity during these early stages. Finally, we present evidence for direct transcriptional repression of
Sox2
by YAP1/WWTR1/TEAD4. Taken together, our observations reveal that, while embryos are initially competent to express
Sox2
as early as the 4-cell stage, transcriptional repression prevents the premature expression of
Sox2
, thereby restricting the pluripotency program to the stage when inside cells are first created.
Title: TEAD4/YAP1/WWTR1 prevent the premature onset of pluripotency prior to the 16-cell stage
Description:
Abstract
In the mouse embryo, pluripotent cells arise inside the embryo around the 16-cell stage.
During these early stages,
Sox2
is the only gene whose expression is known to be induced specifically within inside cells as they are established.
To understand how pluripotent cells are created, we investigated the mechanisms regulating the initial activation of
Sox2
expression.
Surprisingly,
Sox2
expression initiated normally in the absence of both
Nanog
and
Oct4
, highlighting differences between embryo and stem cell models of pluripotency.
However, we observed precocious, ectopic expression of
Sox2
prior to the 16-cell stage in the absence of
Yap1, Wwtr1
, and
Tead4
.
Interestingly, the repression of premature
Sox2
expression was sensitive to LATS1/2 activity, even though it normally does not limit TEAD4/YAP1/WWTR1 activity during these early stages.
Finally, we present evidence for direct transcriptional repression of
Sox2
by YAP1/WWTR1/TEAD4.
Taken together, our observations reveal that, while embryos are initially competent to express
Sox2
as early as the 4-cell stage, transcriptional repression prevents the premature expression of
Sox2
, thereby restricting the pluripotency program to the stage when inside cells are first created.
Related Results
TEAD4/YAP1/WWTR1 prevent the premature onset of pluripotency prior to the 16-cell stage
TEAD4/YAP1/WWTR1 prevent the premature onset of pluripotency prior to the 16-cell stage
In mice, pluripotent cells are thought to derive from cells buried inside the embryo around the 16-cell stage. Sox2 is the only pluripotency gene known to be expressed specifically...
Abstract 1098: Activation of YAP1 confers ROS1 inhibitor resistance in ROS1-rearranged lung cancer
Abstract 1098: Activation of YAP1 confers ROS1 inhibitor resistance in ROS1-rearranged lung cancer
Abstract
ROS1 gene arrangements occur in approximately 1% to 2% of non-small cell lung cancers. Crizotinib, the ROS1-tyrosine kinase inhibitor (TKI), has been approv...
Role and mechanism of YAP1 in pan-cancer
Role and mechanism of YAP1 in pan-cancer
Abstract
Backgrounds and aims:
Cancers threaten health and life of patients with tumors. It is important to diagnose and treat various tumors as ...
Gene Regulation Network of Prognostic Biomarker YAP1 in Human Cancers: An Integrated Bioinformatics Study
Gene Regulation Network of Prognostic Biomarker YAP1 in Human Cancers: An Integrated Bioinformatics Study
Background: Yes-associated protein 1 (YAP1) is the main downstream effector of the Hippo signaling pathway, which is involved in tumorigenesis. This study aimed to comprehensively ...
MUC13 Enhances Colorectal Cancer Metastasis
MUC13 Enhances Colorectal Cancer Metastasis
Colorectal cancer (CRC) is one of the most prevalent cancer worldwide with a 5% lifetime incidence in developed countries. It is third most common cause of cancer related death in ...
Data from Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma
Data from Targeting Hippo-Dependent and Hippo-Independent YAP1 Signaling for the Treatment of Childhood Rhabdomyosarcoma
<div>Abstract<p>Rhabdomyosarcoma is the most common childhood soft-tissue sarcoma, yet patients with metastatic or recurrent disease continue to do poorly, indicating a...
Abstract 1819: The immunosuppressive role of YAP1 on the tumor immune microenvironment
Abstract 1819: The immunosuppressive role of YAP1 on the tumor immune microenvironment
Abstract
Background and aims: Lung adenocarcinoma (LUAD), the most prevalent histologic subtype of non-small cell lung cancer, is one of the most fatal malignancies....
Abstract 2609: Overexpression of YAP1 of EGFR-mutant lung adenocarcinoma before tyrosine kinase inhibitor is associated with poor survival
Abstract 2609: Overexpression of YAP1 of EGFR-mutant lung adenocarcinoma before tyrosine kinase inhibitor is associated with poor survival
Abstract
Purpose: EGFR tyrosine kinase inhibitor (EGFR TKI) was approved as a first line treatment for EGFR mutant lung adenocarcinoma (LADC) with advanced stage. YA...

